Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Promensil and Lifestyle for Menopausal Symptoms in Breast Cancer
NCT03844685Phase 2Completed
- Sponsor
- Fondazione IRCCS - Istituto Nazionale dei Tumori di Milano
- Start
- Jul 2012
- Primary completion
- Mar 2014
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial (2 arms), sponsored by Fondazione IRCCS - Istituto Nazionale dei Tumori di Milano. Primary endpoints: Menopause Rating Scale at 24 months, Weight gain at 24 months and 1 more. Started Jul 2012; status: completed.
Beyond the preview
Go deeper on NCT03844685.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03844685.